Head of Product Launch Program Management (Rare Disease)
Rezolute Inc - Redwood City
Posted Oct 18, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Offered From the posting source checked Nov 16, 2026
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified
- Salary
- $240K-$290K From the posting source checked Nov 16, 2026
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $102,662 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +5.4% - Faster than average
U.S. benchmark only; posted salary is not compared across countries or currencies.
Matched to SOC 11-1021 - Product Management aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Head of Product Launch Program Management (Rare Disease) Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders. More information can be found at rezolutebio.com The Director, Product Launch Program Management is a member of the Program Management Office (PMO), reporting to the Senior Vice President, Operations, and directly supporting the Commercial Product Launch Lead (Head of Marketing). The PLPM owns the integrated launch plan by indication and by market across the U.S. and priority ex-U.S. countries, and facilitates, consolidates, organizes, documents, and measures that plan so the Product Launch Lead and functional leaders can make decisions and deliver against it. The role supports establishment of the launch strategy with specific responsibility to make it complete, current, and executable. Working within the company's governance model, the role works daily within
Read the full description at jobs.lever.co. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Executive Director, Payer Strategy and Engagement (Tumor HI Program)
Rezolute Inc - Redwood City
Rare Diseases Product Manager
Amgen - Argentina - Buenos Aires
(Sr.) Product Manager, Growth Hormone (Regular)
Novo Nordisk A/S - Seoul, Seoul, KR
Partnership Lead, Rare Disease - Western Territories
Biogen - British Columbia, Canada